Labels of all GLP-1 receptor agonists now carry a warning about pulmonary aspiration during general anesthesia or deep sedation. This drug class, involving injectable and oral medications used for ...

The FDA has updated the labels for all GLP-1 receptor agonists, including popular medications Ozempic, Wegovy, Saxenda and Mounjaro, to include a new warning about the risk of pulmonary aspiration ...

Patients using GLP-1 drugs had no difference in the odds of postoperative aspiration pneumonia versus non-users. There was also no significant difference in the odds of acute respiratory failure.

ALAMEDA, Calif.--(BUSINESS WIRE)--Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration 510(k) clearance for ...

Stopping GLP-1 therapy may disrupt glycemic control and reduce cardiovascular benefits without clear perioperative safety ...

The first comparative analysis from the ENGULF (A Safety and Feasibility Single-Arm Study of a Novel Catheter Thrombectomy Device For the Treatment of Pulmonary Embolism) trial shows that using blood ...

The most severe clinical problem which coexist with the meconium aspiration syndrome/MAS/is persistent pulmonary hypertension/PPHN/. The aim of our study was to evaluate the efficacy of treatment of ...

CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc. today announced positive efficacy and safety results from the pivotal SYMPHONY-PE Trial (NCT06062329) evaluating the company’s Symphony® ...

In this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information by sharing relevant background and reasoning ...